Comparision of the effect between Mammotome assisted minimally invasive atherectomy and traditional surgery in treatment of youth giant breast fibroadenoma
10.3760/cma.j.issn.1674-6090.2018.02.009
- VernacularTitle:Mammotome微创旋切术与传统开放手术切除青春期乳房巨大纤维腺瘤的疗效分析
- Author:
Yuejun QIAN
1
;
Jin LYU
;
Yingxu YANG
;
Hongjun HAO
Author Information
1. 郑州大学附属郑州中心医院
- Keywords:
Mammotome minimally invasive atherectomy;
Traditional open surgery;
Youth breast giant fibroadenoma
- From:
Chinese Journal of Endocrine Surgery
2018;12(2):124-127
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the effect between Mammotome minimally invasive surgery and traditional surgery in resection of youth giant breast fibroadenoma (YGBF).Methods We randomly selected 73 patients who had YGBF and already accepted surgical treatment in our hospital from Jul.2009 to Jan.2016.The 75 patients recruited from screening programmes were alloted to either treatment according to their choice (37 cases in MS and 38 cases in traditional surgery).The median follow-up was 18 months (from 6 to 36 months).Comparative analysis was done between the two groups in operation time,incision healing time,incision length,intraoperative bleeding,wound infection,subcutaneous hematoma,residual tumor,breast deformation,scar size,and patient satisfaction degree.Results There was no statisticaly significant difference betwen these two groups in operation time,intraoperative blood loss,incision infection,subcutaneous hematoma,or residual tumor (P＞0.05),however,MS group was superior to traditional surgery group in the incision healing time,incision length,breast deformation,scar size and postoperative satisfaction degree,and the difference was statistically significant(P＜ 0.05).Conclusion The advantage of Mammotome minimally invasive operation auxiliary for YGBF is obvious,such as fast wound healing,small incision,infection rate,small breast without deformation and scar etc.,also higher satisfaction degree to the treatment,which is regarded as the preferred surgical treatment for YGBF patients.
